Equol (7-hydroxy-3(4'hydroxyphenyl)-chroman), the major metabolite of the phytoestrogen daidzein, specifically binds and blocks the hormonal action of 5adihydrotestosterone (DHT) in vitro and in vivo. Equol can bind circulating free DHT and sequester it from the androgen receptor, thus altering growth and physiological hormone responses that are regulated by androgens. These data suggest a novel model to explain equol's biological properties. The significance of equol's ability to specifically bind and sequester DHT from the androgen receptor have important ramifications in health and disease and may indicate a broad and important usage for equol in the treatment and prevention of androgen-mediated pathologies of skin and hair. Thus, equol can specifically bind DHT and prevent DHT's biological actions in physiological and pathophysiological processes affecting skin and hair.
Equol(7-羟基-3(4'羟基苯基)-色满)是植物
雌激素黛泽素的主要代谢产物,在体外和体内能特异性地结合并阻断 5-二氢
睾酮(DHT)的荷尔蒙作用。Equol能与循环中的游离DHT结合,并将其从雄激素受体中分离出来,从而改变受雄激素调节的生长和生理激素反应。这些数据为解释 Equol 的
生物特性提供了一个新的模型。马郁兰能够特异性地与雄激素受体结合并从雄激素受体中螯合 DHT,这在健康和疾病方面具有重要意义,可能预示着马郁兰在治疗和预防雄激素介导的皮肤和毛发病变方面具有广泛而重要的用途。因此,在影响皮肤和头发的生理和病理生理过程中,马郁兰可以特异性地结合 DHT 并阻止 DHT 的
生物作用。